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Abstract
Background: Sertraline is a well known antidepressant drug which belongs to a class called selective serotonin
reuptake inhibitor. Most published methods do not enable studying the stability of this drug in different stress
conditions.
Results: Two new methods were developed for the determination of sertraline (SER). Both methods are based on
coupling with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) in borate buffer of pH 7.8 and measuring the
reaction product spectrophotometrically at 395 nm (Method I) or spectrofluorimetrically at 530 nm upon excitation
at 480 nm (Method II). The response-concentration plots were rectilinear over the range 2-24 μg/mL and 0.25-5
μg/mL for methods I and II respectively with LOD of 0.18 μg/mL and 0.07 μg/mL, and LOQ of 0.56 μg/mL and
0.21 μg/mL for methods I and II, respectively.
Conclusion: Both methods were applied to the analysis of commercial tablets and the results were in good
agreement with those obtained using a reference method. The fluorimetric method was further applied to the in
vivo determination of SER in human plasma. A proposal of the reaction pathway was presented. The
spectrophotometric method was extended to stability study of SER. The drug was exposed to alkaline, acidic,
oxidative and photolytic degradation according to ICH guidelines. Moreover, the method was utilized to
investigate the kinetics of oxidative degradation of the drug. The apparent first order rate constant and t1/2 of the
degradation reaction were determined.
Background
Sertraline is selective serotonin reuptake inhibitor which
is clinically effective for the treatment of depression,
obsessive-compulsive disorder, depression relapse and
social phobia [1]. Chemically it is (1S,4S)-4 [3,4-dichloro-
phenyl]-1,2,3,4 tetrahydro-N-methyl-1-naphthylamine [2]
(Figure 1). Various methods have been reported for the
determination of sertraline (SER) including spectropho-
tometry through it’s reaction with some acidic dyes [3]
and some haloquinones [4].
A good guide to the work published is found in the
comprehensive monographs in its analytical profile
series [5] It was also determined in biological fluids and
dosage forms by GC [6-8] MS,GC [9] and HPLC meth-
ods [10-13].
Most of these methods are either tedious or require
highly sophisticated instrumentation. Therefore, our tar-
get was to develop simple and sensitive spectrofluori-
metric and spectrophotometric methods for the
determination of SER in pharmaceutical preparations
and biological fluids.
4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) is a
useful derivatizing agent for primary amines, secondary
amines, thiols, etc.. Several pharmaceutical compounds
have been determined through this approach [14-20].
During preparation of this manuscript, a paper on the
spectrofluorimetric determination of SER appeared [21].
However, the paper did not deal neither with the
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study of the drug. Since the purpose of stability studies
is to monitor possible changes to a product or a mate-
rial over a time at different storage conditions, it is
expected that, only those methods that are stability-
indicating should be used.
The parent drug stability guidelines issued by the
international conference of harmonization (ICH) [22]
requires that analytical test procedure should indicate
stability. Therefore, the present study was extended to
establish the inherent stability of SER under different
stress conditions such as, alkaline, acidic, oxidative and
photolytic conditions.
Experimental
Apparatus
Spectrophotometric analysis was carried out on a Shi-
madzu (Kyoto, Japan) UV-1601 PC, UV-Visible double-
beam spectrophotometer with matched 1 cm path-length
quartz cells. Absorption spectra were recorded on a fast
scan speed, setting slit width to be 1 nm and sampling
interval to be auto.
The spectrofluorimetric measurements were made
using Perkin Elmer LS 45 Luminescence Spectrometer
e q u i p p e dw i t h1 5 0W a t tX e n o na r cl a m pa n dq u a r t z
cell (1 cm).
Materials and Reagents
All reagents and solvents were of Analytical Reagent
grade.
- The pure sample of sertraline (SER) was kindly sup-
plied by the Egyptian Company for Chemicals and Phar-
maceuticals (ADWIA) (10
th of Ramadan City, Egypt), with
a purity of 99.78% as determined by the reference method
[23]. The following preparations containing the drug were
purchased from local pharmacies:
▪ Seserine
® tablets, batch # 080371, labeled to con-
tain 56.0 mg SER HCl equivalent to 50.0 mg SER/
tablet, product of ADWIA Co. S.A.E, 10
th of Rama-
dan City, Egypt.
▪ Serlift
® tablets, batch # 810102, labeled to con-
tain SER HCl equivalent to 100.0 mg SER/tablet,
product of Global Napi Pharmaceuticals for REXCEL
EGYPT.
▪ Lustral
® tablets, batch # 9201, labeled to contain
50.0 mg of SER/tablet, product of Pfizer Egypt S.A.E.
Cairo.
- Plasma was kindly provided by Mansoura University
Hospital, and kept frozen until use after gentle thawing.
- 4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl )
purchased from Sigma ( St.Louis USA). A stock solution
containing 0.2% (w/v) of the reagent was freshly pre-
pared in methanol.
-Methanol, hydrochloric acid and diethyl ether
(Merck, Darmstadt, Germany).
- Borate buffer (0.2 M, pH 7.8), phosphate buffer
(0.2M, pH 12).
- 1.0 M aqueous solution of sodium hydroxide (BDH,
UK).Hydrogen peroxide (BDH, UK); 0.1% (v/v) aqueous
solution
Standard solution
A stock solution was prepared by dissolving 20.0 mg of
SER in 100 mL of methanol and was further diluted with
the same solvent as appropriate. The standard solutions
were stable for seven days when kept in the refrigerator.
General Procedure
Construction of the Calibration Curve
a) Spectrophotometric method (Method I) To a set of
10 mL volumetric flasks, aliquot volumes containing the
drug were quantitatively transferred to obtain final con-
centrations of 2-24 μg/mL of SER. 2.0 mL of borate buffer
(pH 7.8) followed by 1 mL of NBD-Cl solution (0.2% w/v)
and were mixed well. The solutions were heated in a ther-
mostatically controlled water bath at 60°C for 25 min. The
reaction was stopped by cooling under tap water, and then
0.2 mL of concentrated HCl was added. The solutions
were quantitatively transferred to 10 mL volumetric flasks
a n de a c hf l a s kw a sm a d eu pt ov o l u m ew i t hm e t h a n o l .
The absorbance was measured at 395 nm against a reagent
blank. The calibration graph was constructed by plotting
the absorbance versus the final concentration of the drug
(μg/mL). Alternatively, the corresponding regression equa-
tion was derived.
b) Spectrofluorimetric method (Method II) The proce-
dure adopted for spectrophotometric method was per-
formed after dilution of the standard solution to obtain
the working concentration range of 0.25-5 μg/mL. The
fluorescence intensity of the resulting solutions was
measured at 530 nm after excitation at 480 nm. The
corrected fluorescence intensity (ΔF) was plotted vs the
final concentrations of the drug (μg/mL) to get the cali-
bration curve. Alternatively, the regression equation was
derived.
Figure 1 Structural formula of SER.
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Procedure for commercial tablets
Ten tablets were finely powdered and pulverized well. A
weighed quantity of the powdered tablets equivalent to
20 mg of SER was transferred into a 100 mL volumetric
flask, about 80 mL of methanol was added and the flask
was sonicated for 15 min. The volume was completed
with methanol, mixed well and filtered. Aliquots con-
taining suitable concentrations of SER were analyzed as
described under Construction of the Calibration Graph.
The nominal content of the tablets was determined
either from the calibration curve or using the corre-
sponding regression equation.
Procedure for spiked human plasma
Control samples of plasma (1 mL) were spiked with
increasing quantities of SER to give a final drug concentra-
tion of 0.2-0.4 μg/mL. 2 mL of acetone was added to
1.0 mL of the spiked plasma and was shaked gently. Then
the mixture was centrifuged at 6000 rpm for 10 min. The
clear supernatant was separated and then 1 mL phosphate
buffer (pH 12) was added. After which 3 × 5 mL diethyl
ether was used for extraction and the mixture was centri-
fuged. The ethereal layer was evaporated to dryness. The
residue was reconstituted in 2.0 mL of methanol, and then
method II was performed as described under Construction
of the Calibration Graph. The nominal content of the
drug was determined using the corresponding regression
equation.
Stability Indication of the Method
Forced Degradation Studies
1- Alkaline Degradation Solutions for alkaline degrada-
tion were prepared by dissolving 100 mg of SER in the
least amount of methanol, and the volume was completed
to 100 mL in a volumetric flask with 5.0 M sodium hydro-
xide, then the solution was heated in a boiling water bath
for three hours. Then aliquot volumes of these solutions
were transferred to 10 mL volumetric flasks and treated as
described under method I under Construction of the Cali-
bration Graph.
2- Acidic Degradation The same method for alkaline
degradation was followed using 5.0 M hydrochloric acid
instead of 5.0 M sodium hydroxide. Then aliquot volumes
of these solutions were transferred to 10 mL volumetric
flasks and treated also as described under method I under
Construction of the Calibration Graph.
3- Photolytic Degradation Solutions for photolytic
degradations were prepared by dissolving 100 mg of SER
in the least amount of methanol, and the volume was
completed to 25 mL in a volumetric flask with the same
solvent. The solution was exposed to UV-Lamp at a wave-
length of 245 nm at a distance of 15 cm placed in a woo-
den cabinet for 24 and 48 hours. Then aliquot volumes of
these solutions were transferred to 10 mL volumetric
flasks and treated as described for method I under Con-
struction of the Calibration Graph.
Oxidative Degradation Studies
For the kinetic study of the oxidative degradation, aliquots
of SER stock solution were quantitatively transferred to
50 mL volumetric flasks so that the final concentration is
100 μg/mL, then 5 mL of 1% (v/v) H2O2 was added so
that its final concentration is 0.1% (v/v) and the solution
was heated at different temperature settings using a ther-
mostatically controlled water bath then allowed to cool.
Each flask was completed to volume with methanol and
aliquots of these solutions were transferred to 10 mL volu-
metric flasks so that the final concentration is 20 μg/mL.
The procedure described for method I under Construction
of the Calibration Graph was performed.
Results and Discussion
In the present study, SER was found to react with NBD-Cl
in presence of borate buffer (pH 7.8) producing a yellow
color peaking at 395 nm. (Figure 2) and resulting in a
strong fluorescence at 530 nm after excitation at 480 nm
(Figure 3).
Optimization of Experimental parameters
The spectrofluorimetric and spectrophotometric proper-
ties of the colored product as well as the different experi-
mental parameters affecting the color development and its
stability were carefully studied and optimized. Such factors
were changed individually while others were kept constant.
The factors include pH, type of buffer, temperature, time
of heating, effect of surfactants and effect of diluting
solvent.
Effect of pH
The influence of pH on the absorbance of the reaction
product was evaluated. Maximum absorbance intensity
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Figure 2 Absorption Spectra. (a) SER (20 μg/mL) in borate buffer
of pH 7.8. (b) The reaction product of SER (20 μg/mL) with NBD-Cl
in borate buffer of pH 7.8. (c) Blank solution with NBD-Cl in borate
buffer of pH 7.8.
Walash et al. Chemistry Central Journal 2011, 5:61
http://journal.chemistrycentral.com/content/5/1/61
Page 3 of 11was obtained at pH 7.7 and remained constant up to 7.9
after which the absorbance of the reaction product
began to decrease gradually until pH 9. Therefore, pH
of 7.8 ± 0.1 was chosen as the optimum one (Figure 4).
Other buffers having the same pH value such as phos-
phate and hexamine were tried and compared with
0.2 M borate buffer. Borate buffer was found to be
superior to other buffers having the same pH value since
the net fluorescence intensity was highest in case of
borate buffer. This is probably, because the rate of hydro-
lysis of NBD-Cl to NBD-OH was much slower. This
result is in agreement with that of Miyano et al [24].
Effect of concentration of NBD-Cl
The influence of the concentration of NBD-Cl was stu-
died using different volumes of 0.2% w/v solution of the
reagent. It was found that, the reaction of NBD-Cl with
SER started upon using 0.2 mL of the reagent in the
presence of borate buffer (pH 7.8). Increasing the
volume of the reagent, produces a proportional increase
in the absorbance of the reaction product up to 0.8 mL
and remains constant up to 1.2, after which further
increase produces a gradual decrease in the absorbance
value. Therefore, 1 mL of 0.2% w/v of NBD-Cl solution was
chosen as the optimal volume of the reagent (Figure 5).
Effect of heating temperature
Different temperature settings were used with constant
heating time. Increasing the temperature of the water
bath was found to produce a proportional increase in
the absorbance of the reaction product up to 55°C and
remained constant until 65°C after which further
increase in the temperature produces a gradual decrease
in the absorbance value, so the optimum temperature
for study was 60°C ± 5°C (Figure 6).
Effect of time
The time of heating is an essential part of the experi-
ment. Different time intervals were tested to ascertain
the time after which the solution attains its highest
absorbance. It was found that after 25 min, the reaction
product reaches the highest absorbance (Figure 7). It
was observed that heating time for 25 min is adequate
and the absorbance of the reaction product is stable for
about 40 min. at room temperature.
The fluorescence intensity or absorbance value of the
hydrolysis product of NBD-Cl, namely,4-hydroxy-7-
nitrobenzo-2-oxa-1,3-diazole (NBD-OH) is quenched by
decreasing the pH of the reaction medium to less than
1. Therefore, acidification of the reaction mixture prior
to measurement of the fluorescence intensity or absor-
bance value remarkably decreased the background fluor-
escence or absorbance due to the formation of NBD-
OH without affecting the drug reagent adduct, hence
the sensitivity was increased.
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Figure 3 Fluorescence spectra of the reaction product.( A ,B )
SER ( 2.5 μg/mL) with 0.2% NBD-Cl at pH 7.8. (A’,B ’) blank with
0.2% NBD-Cl at pH 7.8.
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Figure 4 Effect of pH of borate buffer 0.2 M on the
absorbance of the reaction product of SER (20 μg/mL) with
NBD-Cl.
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Figure 5 Effect of volume of NBD-Cl 0.2% (w/v) on the
absorbance of the reaction product of SER (20 μg/mL) with
NBD-Cl.
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Dilution with different solvents such as methanol, water,
acetone, dimethylsulfoxide and dimethylformamide was
studied. The highest absorbance value was achieved
upon diluting with methanol.
Effect of surfactant
The influence of concentration of different surfactants on
the absorbance of the reaction product was studied hope-
fully they may enhance the absorbance. It was found that
by using different concentrations of sodium dodecyl sul-
phate or cetrimide, there was a negligible increase in the
absorbance, while using gelatine decreases the absorbance;
therefore the study was performed omitting any surfactant.
Analytical parameters for Sertraline
Validation of the proposed methods
The validity of the methods was tested regarding linearity,
specificity, accuracy, repeatability and precision according
to ICH Q2B recommendations [22].
Linearity
The absorbance-concentration plot was linear over the
range of 2-24 μg/mL with minimum detection limit
(LOD) of 0.18 μg/mL. While, the fluorescence-
concentration plot was found to be linear over the range
of 0.25-5 μg/mL with LOD of 0.07 μg/mL. Linear regres-
sion analysis of the data gave the following equations:
A = 0.0389 + 0.0352 C (r = 0.9999)
F = 19.038 + 31.814 C (r = 0.9999)
Where A is the absorbance in 1-cm cell, F is the cor-
rected fluorescence intensity, and C is the concentration
of the drug in μg/mL.
The limits of quantification (LOQ) and the limits of
detection (LOD) were calculated according to ICH Q2B
[22] using the following equations:
LOQ = 10Sa/b LOD = 3.3Sa/b
Where Sa = The standard deviation of the intercept of
regression line
b = Slope of the calibration curve.
The results are shown in Table 1.
LOQ were 0.56 and 0.21 μg/mL for methods I and II
respectively, while LOD were 0.18 and 0.07 μg/mL for
methods I and II respectively.
These small values allowed the determination of SER
in spiked human plasma using method II.
The proposed methods were evaluated by studying the
accuracy as percent relative error (% Er) (table 1) and
precision as percent relative standard deviation (% RSD)
and the results are shown in table 1. The small values of
% Er and % RSD indicates high accuracy and high preci-
sion of the proposed methods.
Accuracy
To test the validity of the proposed methods, they were
applied to the determination of pure sample of SER
over the working concentration ranges. The results
obtained were in good agreement with those obtained
using reference method [23]. Using Student’st - t e s ta n d
variance ratio F-test [25], revealed no significant differ-
ence between the performance of both methods and
reference method regarding the accuracy and precision,
respectively. The reference method recommended an
HPLC determination of SER in pure and dosage forms
using a mixture of 35% acetonitrile: methanol (92:8, v/v)
and 65% of sodium acetate buffer at pH 4.5 as mobile
phase with UV detection at 230 nm.
The validity of the two methods were evaluated by
statistical analysis of the regression lines regarding the
standard deviation of the residuals (Sy/x), the standard
deviation of the intercept (Sa) and standard deviation of
the slope (Sb) .T h er e s u l t sa r eg i v e ni nT a b l e1 .T h e
small values of the figures point out to the low scatter-
ing of the calibration graph and the precision of the
methods.
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Figure 6 Effect of heating temperature on the absorbance of
the reaction product of SER (20 μg/mL) with NBD-Cl.
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Figure 7 Effect of heating time on the absorbance of the
reaction product of SER (20 μg/mL) with NBD-Cl.
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Repeatability
The repeatability was performed by applying the pro-
posed methods for the determination of two concentra-
tions of SER in pure form on three successive times,
and the results are listed in Table 2.
Intermediate precision
It was performed through repeated analysis of SER in
pure form, using the concentrations shown in Table 2
for a period of 3 successive days. The results are also
summarized in Table 2.
Robustness of the method
The robustness of the methods adopted is demonstrated
by the constancy of the fluorescence intensity/absorbance
value with the deliberated minor changes in the experi-
mental parameters such as, change in pH 7.8 ±0.1, change
in the volume of NBD-Cl (0.2% w/v), 1.0 ± 0.2 mL, the
change in reaction time 25 ± 5 min. These minor changes
that may take place during the experimental operation
didn’t affect the fluorescence intensity or the absorbance
value of the reaction products.
Pharmaceutical Applications
The proposed methods were then applied to the deter-
mination of SER in its tablets. The methods were tested
for linearity, selectivity and accuracy according to ICH
Q2B recommendations [22].
Selectivity
The selectivity of the method was investigated by obser-
ving any interference encountered from the common
tablet excepients, such as talc, lactose, starch, avisil,
gelatine, and magnesium stearate. These excepients did
not interfere with the proposed methods. As revealed by
a blank experiment using tablets additives but omitting
sertraline.
Accuracy
The results of the pharmaceutical applications of the
proposed methods were statistically compared with
those obtained using the reference method [23]. Statisti-
cal analysis [25], of the results, using Student’st - t e s t
and variance ratio F-test revealed no significant differ-
ence between the performance of the proposed and
reference methods regarding the accuracy and precision,
respectively (Table 3).
Analysis of Biological fluids
The high sensitivity of the proposed fluorimetric method
allowed the determination of SER in spiked human
plasma (Figure 8). Sertraline is given orally in a dose of
100 mg three times daily; this leads to a final blood level
concentration of about 0.25 μg/mL i.e can be deter-
mined by the proposed method. The results are shown
in Table 4. The extraction procedure described by Kim
et.al [26] was adopted here. The results are satisfactorily
accurate and precise.
Precision
The within-day precision was evaluated through repli-
cate analysis of plasma samples spiked with increasing
concentrations of the drug. The percentage recoveries
Table 1 Performance data of the proposed method
Parameter Spectrofluorimetric Method Spectrophotometric Method Ref. method [23]
-concentration range (μg/mL ). 0.25-5 2-24
-LOD (μg/mL ). 0.069 0.184
-LOQ (μg/mL). 0.209 0.558
-Correlation coefficient ( r). 0.9999 0.9999
-Slope 31.8 0.035
-Intercept 19.038 0.039
-Sy/x 0.928 2.72 × 10
-3
-Sa 0.664 1.96 × 10
-3
-Sb 0.221 1.387 × 10
-4
-% Error 0.29 0.21
-%RSD 0.65 0.51
-No.of Experiments. 5 6 3
-Mean found (%) 100.12 100.74 100
± SD. 0.65 0.51 0.31
-Student’s t-value. 0.275 (2.45) 2.216 (2.37)
-Variance ratio F-test. 4.352 (19.25) 2.762 (19.30)
-Applications. tablet preparations and spiked human plasma
N.B.
-Sy/x =standard deviation of the residuals.
-Sa = standard deviation of the intercept of regression line.
-Sb = standard deviation of the slope of regression line
-% Error = RSD%/√ n.
- Figures between parentheses are the tabulated t and F values respectively, at p = 0.05.[25]
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Sample concentration % recovery (repeatability) % recovery Intermediate precision
Method I
12 μg/mL 100 101.34
102 102
100.9 102
X’ 100.78 101.78
±S D 0.90 0.47
%RSD 0.90 0.47
% Error 0.45 0.26
20 μg/mL 101 100
100.55 99.76
99 98.56
X’ 100.18 99.44
±S D 1.1 0.85
%RSD 1.1 0.85
% Error 0.63 100
Method II
2 μg/mL 98.50 102
98.43 101.5
99 101.8
X’ 98.64 101.77
±S D 0.40 0.21
%RSD 0.40 0.21
% Error 0.24 0.12
4 μg/mL 99 99
99.88 98.5
98.88 100
X’ 99.25 99.17
±S D 0.69 1.06
%RSD 0.69 1.06
% Error 0.40 0.62
Table 3 Application of the proposed methods to the determination of SER in tablets
preparation Spectrophotometric method Ref. method [23]
Amount taken (μg/mL) % found Amount taken (μg/mL) % found
Seserine tablets (56.0 mg SER HCl/Tablet equivalent to 50.0 mg SER) 12.0 100.76 0.5 100.36
20.0 99.05 1.0 99.87
24.0 100.00 2.0 99.56
X
-± SD 99.94 ± 0.54 99.93 ± 0.40
Student’s t test 0.610
Variance ratio F test 5.824
Serlift tablets (100.0 mg SER HCL/Tablet) 12.0 101.00 0.5 99.65
20.0 100.05 1.0 100.89
24.0 100.50 2.0 100.25
X
- ± SD 100.52 ± 0.32 100.26 ± 0.62
Student’s t test 0.562
Variance ratio F test 1.702
Lustral tablets (50.0 mg of SER/Table) 12.0 98.430 0.5 100.23
20.0 98.187 1.0 100.43
24.0 98.850 2.0 98.51
X
-± SD 98.49 ± 0.17 99.72 ± 1.06
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were 101.05 ± 1.65, thus indicating the high precision of
the method (Table 4).
The inter-day precision was also evaluated through
replicate analysis of plasma samples spiked with 0.4 μg/
mL of drug on three successive days. The percentage
recoveries based on the average of four separate deter-
minations were 101.94 ± 1.194. The results are also
shown in Table 4.
Mechanism of the reaction
The stoichiometry of the reaction was studied adopt-
ing the limiting logarithmic method [27]. The absor-
bance of the reaction product was alternatively
measured in the presence of excess of either NBD Cl
or SER. A plot of log absorbance versus log [NBD-Cl]
and log [SER] gave straight lines, the values of the
slopes were 0.79 and 0.83 respectively (Figure 9).
Hence, it is concluded that, the molar reactivity of the
reaction is 0.79/0.83, i.e. the reaction proceeds in the
r a t i oo f1 :1 .B ya n a l o g yt op r e v i o u ss t u d y[ 1 6 ] ,i ti s
confirmed that one molecule of the drug reacts with
one molecule of NBD-Cl. Sertraline in alkaline med-
ium reacts with NBD-Cl through its secondary amino
group to give the following final reaction product. A
schematic proposal of the reaction pathway is given in
Scheme 1.
Stability indication of the method
Forced degradation studies of SER
In order to establish whether the analytical method was
stability-indicating or not, SER was exposed to different
forced degradation studies. The stability of SER has been
studied under extreme challenge conditions as well as the
more traditional pharmaceutical challenge conditions.
M e t h a n o lw a su s e da sad i l u t i n gs o l v e n ti na l lf o r c e d
degradation studies. The drug was found to be highly
Table 3 Application of the proposed methods to the determination of SER in tablets (Continued)
Student’s t test 1.930
Variance ratio F test 9.903
Spectrofluorimetric method
Seserine tablets (56.0 m g SER HCl/Tablet equivalent to 50.0 mg SER) 2.0 99.99 0.5 100.36
3.0 100.05 1.0 99.87
5.0 98.55 2.0 99.56
X
-± SD 99.53 ± 1.06 99.93 ± 0.40
Student’s t test 0.737
Variance ratio F test 4.433
Serlift tablets (100 0 mg SER HCL/Tablet 2.0 99.60 0.5 99.65
3.0 98.56 1.0 100.89
5.0 100.00 2.0 100.25
X
-± SD 99.39 ± 1.02 100.26 ± 0.62
Student’s t test 1.569
Variance ratio F test 1.437
Lustral tablets (50.0 mg of SER/Tablet) 2.0 101.05 0.5 100.23
3.0 100.55 1.0 100.43
5.0 99.56 2.0 98.51
X
- ± SD 100.39 ± 0.70 99.72 ± 1.06
Student’s t test 0.884
Variance ratio F test 1.938
N.B.:
The tabulated values of t and F are (2.78) and (19.00) respectively, at p = 0.05. [25]
Each result is the average of three separate determinations.
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Figure 8 Fluorescence emission spectra of plasma spiked with
SER. (a) Blank, (b) 0.25 μg/mL, (c) 0.3 μg/mL, and (d) 0.35 μg/mL.
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tion conditions as revealed from the constant absorbance
values of samples treated with concentrated solutions of
NaOH or HCl and UV-light.
Oxidative degradation studies
Degradation kinetics study
For the kinetic study, 0.1% (v/v) of hydrogen peroxide was
used for the oxidative degradation of the drug. The degra-
dation was found to follow first order kinetics and to be
temperature dependent (Figure 10). The apparent first
order degradation rate constant (Kobs)a n dt h eh a l fl i f e
time (t1/2) at each temperature were calculated (Table 5).
Plotting log Kobs values versus 1/T, the Arrhenius plot was
obtained (Figure 11). The activation energy was calculated
and found to be 6.38 k.Cal.Mol
-1.
The tolerance limit (concentration of interfering sub-
stance causing 3.0% relative error) of the degradation pro-
duct was measured after mixing increasing concentrations
of the degradation product with 10 μg/mL pure SER. The
tolerance limit was found to be 20%, i.e. up to 20% from
the degradation product will not cause interference in the
proposed spectrophotometric method (Table 6).
Pathway of degradation
By analogy to previous report [28] discussing the degra-
dation of isradipine (containing secondary amino group)
by hydrogen peroxide, it is suggested that the
Table 4 Application of the proposed spectrofluorimetric method to the determination of SER in spiked human plasma.
Sample Amount added (μg/mL) Amount found (μg/mL) % Recovery
1-Plasma (intra-day precision)
0.2 0.209 104.50
0.25 0.242 96.80
0.30 0.295 98.33
0.35 0.347 99.14
0.40 0.407 101.75
Mean ± SD 100.10
3.04
2-Plasma (inter-day precision) 0.30 0.270 90.00
0.30 0.270 90.00
0.30 0.280 93.33
Mean ± SD 91.11
1.92
N.B.:
Each result is the average of three separate determinations.
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Figure 9 Limiting logarithmic plots for the molar reactivity of
SER with NBD-Cl. (A) log A vs log [NBD-Cl]. (B) log A vs log [SER].
Scheme 1 Proposed reaction pathway between NBD-Cl and
sertraline.
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Page 9 of 11degradation pathway is viat h ef o r m a t i o no fN -o x i d e
derivative (Scheme 2).
Conclusion
Two sensitive, simple and time saving methods were
developed for the determination of SER either per se or in
pharmaceutical preparations. By virtue of high sensitivity
of the proposed fluorimetric method, it could be applied
to the determination of SER in spiked human plasma with
good accuracy and precision. The spectrophotometric
method is also considered as stability indicating assay.
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